Mind Medicine earnings were -$108.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MNMD earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$34.7M, up 153.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MNMD reported annual earnings of -$108.7M, with 13.5% growth. The next MNMD earnings date is May 6, 2025.
On MNMD's earnings call on Invalid Date, Mind Medicine (NASDAQ: MNMD) reported Q4 2024 earnings per share (EPS) of -$0.42, up 28.81% year over year. Total MNMD earnings for the quarter were -$34.74 million. In the same quarter last year, Mind Medicine's earnings per share (EPS) was -$0.59.
The next MNMD earnings date is Invalid Date. Add MNMD to your watchlist to be reminded of Mind Medicine's next earnings date.
Is Mind Medicine profitable or losing money?
As of the last Mind Medicine earnings report, Mind Medicine is currently losing money. Mind Medicine's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$108.68 million, a 13.52% increase year over year.
What was MNMD's earnings growth in the past year?
As of Mind Medicine's earnings date in Invalid Date, Mind Medicine's earnings has grown year over year. MNMD earnings in the past year totalled -$108.68 million.
What are Mind Medicine's earnings expectations?
The current EPS estimate for Mind Medicine's earnings report in Invalid Date is -$0.53.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.